Clinical, pathologic, immunologic and virologic features of simian varicella virus (SVV) infection in primates closely resemble varicella-zoster virus (VZV) infection in humans. Such similarities provide a rationale to analyze SVV infection in primates as a model of varicella pathogenesis and latency. Thus, we constructed an SVV-expressing green¯uorescent protein (SVV ± GFP) by inserting the GFP gene into the unique short segment of the virus genome by homologous recombination. Analysis of recombinant viral DNA and the expressed proteins of plaque-puri®ed SVV ± GFP con®rmed the location of the GFP insert and that the recombinant SVV expressed the 27 kDa GFP. Infection of monkey kidney cells in tissue culture with SVV ± GFP revealed bright green¯uorescence associated with the characteristic focal cytopathic effect produced by SVV infection. Microscopic examination of lung from a 3-month-old African green monkey 10 days after infection with SVV ± GFP revealed bright green¯uorescence in areas of acute necrotizing pneumonitis. SVV ± GFP allows ready identi®cation of cells infected with SVV both in vitro and in vivo, and will be useful for further analysis of varicella pathogenesis and latency in experimentally infected animals ± studies not possible in humans.
Introduction
Varicella-zoster virus (VZV) causes chickenpox (varicella) in children, becomes latent in dorsal root ganglia, and reactivates decades later to produce shingles (zoster). Zoster and its neurologic complications are an important cause of morbidity, and occasionally mortality, particularly in the elderly and immunocompromised populations. Any attempt to prevent virus reactivation must begin with an understanding of the physical state of virus during latency, not the least of which is identi®cation of the cell that harbors virus in latently infected human ganglia, including cells that transport virus throughout the nervous system. Such studies require an animal model and a virus marker. The animal model is provided by simian varicella virus (SVV) infection of primates in which clinical (Padovan and Cantrell, 1986) , pathological (Dueland et al, 1992) , immunological (Felsenfeld and Schmidt 1977) and virological (Clarke et al, 1992) features, including latency (Mahalingam et al, 1991) resemble VZV infection in humans. The virus marker is green¯uorescent protein (GFP) from the jelly®sh Aequorea victoria, which emits bright green¯uorescence at 509 nm (Chal®e et al, 1994) . GFP is stable with minimal photobleaching (Chal®e et al, 1994) , and gene encoding GFP has been modi®ed to enhance the¯uorescence several-fold (Zolotukhin et al, 1996) . We inserted the GFP gene into the unique short segment of the virus genome, and observed SVV-infected cells in vitro and in vivo for green¯uorescence.
Results and Discussion
Detection of green¯uorescence in cells infected with SVV ± GFP After transfection with the recombinant clone containing RSV ± GFP (Figures 1 and 2) , we observed bright green¯uorescence associated with a focal cytopathic effect in SVV-infected BSC-1 cells. These foci were puri®ed by passaging through monolayers of BSC-1 cells. Fluorescence detected after infection with puri®ed SVV ± GFP is shown in Figure 3 . Most if not all¯uorescent cells were SVV-positive when analyzed using rabbit anti-SVVantiserum (data not shown). We did not observe any¯uorescence in cells infected with the wildtype SVV (data not shown).
Characterization of SVV ± GFP
We infected BSC-1 cells with plaque-puri®ed SVV ± GFP. We used total DNA extracted from SVV ± GFPand SVV-infected BSC-1 cells in PCR-ampli®ca-tions using SVV-speci®c primers located outside the RSV ± GFP insert (Figure 4) . Upon hybridization using a SVV-speci®c internal oligonucleotide, we detected 1857 bp and 258 bp fragments in DNA from SVV ± GFP-and SVV-infected-BSC-1 cells, respectively. The 258 bp fragment was absent in DNA from SVV ± GFP-infected cells even after 24 h of exposure on phosphoimager (Molecular Dynamics, Sunnyvale, California). The difference in size between the two bands accounted for the 1599 bp RSV ± GFP insert in the SVV genome and con®rmed its insertion at the desired location.
We also extracted total protein from uninfected BSC-1 cells, BSC-1 cells infected with SVV, and BSC-1 cells infected with plaque-puri®ed SVV ± Figure 1 SVV DNA construct containing Rous sarcoma virus RSV ± GFP in the U S segment. The location of the unique long (U L ) and unique short (U S ) segments bounded by internal and terminal repeat sequences (IR S and TR S ), the US2 gene, the poly(A)-addition site for US2, the putative TATA box for the US3 gene, US3, and primers 1, 2, 3 and 4 are indicated. The SmaI site at the 3'-and 5'-ends of primers 3 and 4 is shown. pEGFP and pRC/RSV vectors with the location of BglII (Bg), HindIII (H), BamHI (B) and SspI (S) restriction sites are also identi®ed. The DNA fragment containing RSV ± GFP was cloned into the SmaI site. Figure 2 Extension of SVV sequences¯anking RSV ± GFP. The location of various segments of the SVV genome, the SVV BglII-D fragment, and the BglII (Bg), EagI (Ea), BamHI (B) and HindIII (H) restriction sites, including the NotI (N) site within the RSV ± GFP insert are indicated. the NotI site was mutated and replaced the EagI ± HindIII fragment in the SVV BglII-D recombinant clone with the EagI ± HindIII fragment containing the RSV ± GFP insert. The ®nal 13.5 kb recombinant clone contained RSV ± GFP sequences¯anked by 5240 and 6590 bp of SVV sequences.
GFP, and analyzed them by Western blotting using rabbit antibodies to GFP ( Figure 5 ). We detected a substantial amount of the 27 kDa GFP only among proteins extracted from SVV ± GFP, but not in proteins extracted from uninfected BSC-1 cells, or from SVV-infected BSC-1 cells. Faint bands smaller than 27 kDa seen in Figure 5 are probably due to GFP degradation.
Detection of GFP expression in monkey lung
Our histopathologic examination of monkey lung infected with SVV ± GFP revealed extensive necrosis, in¯ammation and loss of alveoli ( Figure 6 ). Bright green¯uorescence, evident in areas of acute necrotizing pneumonitis, indicated productive infection by SVV expressing GFP. Further, we detected SVV-speci®c antigens in the same area with anti-SVV-antisera ( Figure 6 ). The degree of in¯ammation and distribution of SVV antigens were similar to that seen in monkey lung after infection with wild-type SVV (Dueland et al, 1992) , indicating that in¯ammation was not increased due to GFP expression.
Overall, we showed that SVV ± GFP allows ready identi®cation of cells infected with SVV in vitro and in vivo. The technique will be useful for analysis of varicella pathogenesis as well as to determine the cell-type latently infected with virus in experimentally infected animals ± studies not possible in humans.
Material and methods

Cells and viruses
We propagated SVV and SVV ± GFP by cocultivation of uninfected cells with SVV-infected cells as described (Gilden et al, 1982) .
DNA manipulations
All DNA manipulations were performed using enzymes according to the manufacturer's instructions. Total DNA extracted from SVV-GFP-and SVV-infected BSC-1 cells was used along with SVV-speci®c primers 5 and 6 in PCR ampli®cation. The products were analyzed as described in Methods using a 32 P-labeled SVV-speci®c internal oligonucleotide (Primer 7). The location and direction of GFP, RSV, and primers 5, 6 and 7 sequences on the SVV genome and the sizes of the PCR products are indicated.
Construction of a recombinant clone containing SVV sequences¯anking green¯uorescent protein (GFP) gene We selected the intragenic region between SVV genes US2 and US3 (both located in the U S segment of the SVV genome) to insert the GFP gene (Figure 1 ). We introduced a SmaI site into a DNA fragment containing a portion of the U S segment of the SVV genome which included a part of the US2 ORF, the poly(A) addition signal for US2, the putative promoter (TATA box) for US3, and part of the US3 ORF (Figure 1) . To generate such a DNA fragment, we selected oligonucleotide primers 1, 2, 3 and 4 from the known SVV U S sequences (Gray et al, 1995) . We located a BamHI site downstream from primer 1 and a HindIII site upstream from primer 2 ( Figure   1 ). We designed primers 3 and 4 such that SVVspeci®c sequences were attached at their 3' and 5'-end, respectively, and to an SmaI restriction site sequence (GGGCCC). Using DNA from SVVinfected BSC-1 cells with primers 1 and 3, we ampli®ed a 578 bp PCR product; with primers 2 and 4, we ampli®ed a 354 bp fragment. In a third PCR ampli®cation, we mixed the two PCR products (578 and 354 bp fragments) and used the outside primers 1 and 2. The annealing temperature for the third PCR was 408C for 2 min for seven cycles without any primers followed by 558C for 2 min for 30 cycles using outside primers 1 and 2. The ®nal 936 bp product had an SmaI site at the desired location. We digested the fragment with BamHI and HindIII, obtained a 735 bp DNA fragment and cloned it into BamHI ± HindIII-digested pGem11Zf(+) vector (Promega, Madison, WI). We inserted a 1638 bp DNA fragment containing the RSV promoter (pRC/RSV from Invitrogen, Carlsbad, CA) in front of sequences encoding EGFP (enhanced, redshifted GFP from Clontech, Inc., Palo Alto, CA) into the SmaI site (generated as described above) of the recombinant clone containing the SVV sequences in the pGEM11Zf(+) vector (Promega). The orientation of the insert in the recombinant clone was determined to be BamHI-GFP-RSVHindIII, and the GFP-RSV sequences were¯anked by 470 and 270 bp of SVV sequences from the U S segment of the SVV genome.
Enlargement of¯anking SVV sequences around the RSV ± GFP insert
To abolish the NotI site and a EagI site (part of the NotI site) in the recombinant clone described in Figure 1 , we digested it with NotI (N), bluntended with mung bean nuclease (Gibco BRL Inc., Bethesda, MD) and religated. We digested the recombinant clone with EagI and HindIII and isolated a 2377 bp DNA fragment containing the RSV ± GFP sequences. We digested a recombinant clone containing the 11.9 kb SVV BglII-D fragment in pGem3Z with EagI and HindIII and replaced it with the 2377-bp EagI ± HindIII fragment containing the RSV ± GFP sequences, effectively increasing the size of the SVV sequences anking RSV ± GFP to 5420 and 6590 bp, as shown in Figure 2 .
Puri®cation of SVV expressing GFP
We used lipofectin (Gibco BRL) to transfect SVVinfected BSC-1 cells in tissue culture dishes with the recombinant clone containing RSV ± GFP. Cells uorescing green were identi®ed with a¯uores-cence microscope and transferred onto uninfected BSC-1 cells. We repeated this procedure several times until all cells exhibiting a cytopathic effect were green under UV light, after which SVV ± GFP was plaque-puri®ed. Western blot of total protein from uninfected (BSC-1), SVVinfected (SVV-BSC-1) or SVV ± GFP infected (GFP-SVV-BSC-1) cells after incubation with rabbit anti-GFP followed by alkaline phosphatase-conjugated goat anti-rabbit IgG. The 27 kDa GFP was detected only in total proteins from SVV ± GFP-infected cells.
Analysis of DNA from virus-infected cells
Total DNA from SVV-infected and plaque-puri®ed SVV-GFP-infected cells was extracted and 1 ng of the samples were used in PCR reactions using primers 5 and 6. The products were electrophoretically separated on a 2% agarose gel, transferred to zetaprobe membrane and hybridized to 32 Plabeled internal oligonucleotide (primer 7 in Figure 4 ).
PCR
All PCRs were performed as described (Mahalingam et al, 1991) , with minor modi®cations. Unless speci®ed, all PCRs were cycled with denaturation SVV-speci®c antigen was detected in a section of the lung using rabbit anti-svv-antiserum and (e) no signal was seen using normal rabbit serum. 6216. These results (a ± e) were all from sections that were within 50 microns of each other.
for 1 min at 948C, annealing for 2 min at 558C, and elongation for 3 min at 728C for a total of 34 cycles and a ®nal cycle with denaturation, annealing and elongation times of 1, 2 and 7 min respectively. The sequences of the primers used are given in Table 1 .
Western blot analysis of proteins from virus-infected cells
We scraped 90 mm tissue culture Petri dishes containing 10 6 uninfected or SVV-infected cells into 5 ml of DMEM, washed once in phosphatebuffered saline, and resuspended in 300 ml of lysis buffer (2% SDS, 0.34% NP-40). We passed the lysate through a Qia-shredder cartridge (Qiagen Inc., Chatsworth, CA) to reduce the viscosity, and determined the protein concentration in the eluate using a BCA protein assay system (Pierce Inc., Rockford, IL). We loaded 50 mg of the protein extracts onto an SDS-10%PAGE gel, prepared a Western blot as described (Towbin et al, 1979) and added rabbit anti-GFP antibody (Clontech Inc.) followed by alkaline phosphatase-conjugated goat anti-rabbit IgG, nitro blue tetrazolium and 5-bromo-4-chloro-3-indolyl phosphate for detection as described (Sambrook et al, 1989) .
Inoculation of monkey with SVV expressing GFP and tissue collection
We infected a 3-month-old SVV-seronegative African green monkey intratracheally with 10 4 plaque forming units of SVV ± GFP, and sacri®ced the monkey when viremia appeared seven days later. There was no clinical evidence of varicella. The lungs were ®xed in 4% paraformaldehyde, and 5 mm sections were stained with Harris hematoxylin and eosin and observed by light microscopy. Adjacent unstained sections were observed with an Orthoplan Universal large-®eld Leitz¯uores-cence microscope using a KP490 ®lter, 26 interference blue excitation ®lter and a K530 suppression ®lter.
Preparation of rabbit anti-SVV antiserum SVV nucleocapsid preparations were resuspended in PBS and mixed with Freund's complete adjuvant for subcutaneous inoculation into rabbits. Rabbits were boosted once a month for 5 months with a mixture of SVV nucleocapsids and Freund's incomplete ajuvant. A 1 : 10 dilution of the rabbit antisera was adsorbed with uninfected BSC-1 cells at 378C for 1 h and at 48C for 16 h. The polyclonal sera was then adsorbed with normal monkey liver powder for 30 min and again for 20 h at 48C. The antisera thus obtained was found to react speci®-cally with SVV-infected cells but not with uninfected BSC-1 cells (data not shown).
Immunohistochemistry
Sections of monkey lung were analyzed using rabbit anti-SVV-antiserum as described (Mahalingam et al, 1996) . 
